tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Anderson Schock, 8 are a BUY (100%).
Analyst Anderson Schock, currently employed at B. RILEY, carries an average stock price target met ratio of 50% that have a potential upside of 14.02% achieved within 58 days.
Anderson Schock’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on XGN, Exagen at 05-Aug-2026.
Analyst best performing recommendations are on ANIK (ANIKA THERAPEUTICS).
The best stock recommendation documented was for ANIK (ANIKA THERAPEUTICS) at 7/30/2026. The price target of $21 was fulfilled within 8 days with a profit of $2.93 (16.21%) receiving and performance score of 20.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$-0.5 (-2.33%)
$16
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
Buy Since 22-Feb-2019
$32
$17.24 (116.80%)
$41
Buy Since 15-Nov-2021
$35
$20.24 (137.13%)
$55
Which stock is Anderson Schock is most bullish on?
Which stock is Anderson Schock is most reserved on?
What Year was the first public recommendation made by Anderson Schock?
